How does Feiba work if my body has developed inhibitors that block normal clotting factors?
Feiba contains a mix of clotting factors (II, VII, IX, X) that bypass your inhibitor antibodies and restore thrombin generation—the final step in blood clotting—allowing your blood to clot even when standard factor replacement fails [9].
Hemophilia inhibitors are antibodies your immune system makes against clotting factors VIII or IX. When you receive standard factor replacement, these antibodies neutralize it before it can work. Feiba sidesteps this trap by delivering multiple clotting factors that work together through a different pathway, restoring the final common coagulation cascade [9].
Inside your bloodstream, Feiba's factors interact with your platelets and remaining plasma clotting factors to generate thrombin—the enzyme that converts fibrinogen into fibrin clots. This mechanism bypasses the inhibitor antibodies entirely, so your blood can clot even though your body rejects standard factor VIII or IX [9].
In clinical practice, Feiba stops 70–90% of bleeding episodes in hemophilia inhibitor patients. Dosing is individualized and tailored to tolerability, meaning your hemophilia specialist adjusts the amount based on how well your bleeding stops and how your body tolerates repeated infusions [9].
Ask your hemophilia center: 'How often should I receive Feiba—only when I bleed, or as routine prevention?' Prophylactic dosing (regular infusions) often prevents bleeding better than waiting for a bleed to happen.